Your browser doesn't support javascript.
loading
Piperlongumine synergistically enhances the antitumour activity of sorafenib by mediating ROS-AMPK activation and targeting CPSF7 in liver cancer.
Zheng, Liyun; Fang, Shiji; Chen, Aifang; Chen, Weiqian; Qiao, Enqi; Chen, Minjiang; Shu, Gaofeng; Zhang, Dengke; Kong, Chunli; Weng, Qiaoyou; Xu, Suqin; Zhao, Zhongwei; Ji, Jiansong.
Afiliación
  • Zheng L; Key Laboratory of Imaging Diagnosis and Minimally Invasive Intervention Research, Fifth Affiliated Hospital of Wenzhou Medical University, Lishui 323000, China; Department of Radiology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China.
  • Fang S; Key Laboratory of Imaging Diagnosis and Minimally Invasive Intervention Research, Fifth Affiliated Hospital of Wenzhou Medical University, Lishui 323000, China; Department of Radiology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China.
  • Chen A; The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Suzhou 215000, China.
  • Chen W; Key Laboratory of Imaging Diagnosis and Minimally Invasive Intervention Research, Fifth Affiliated Hospital of Wenzhou Medical University, Lishui 323000, China.
  • Qiao E; Key Laboratory of Imaging Diagnosis and Minimally Invasive Intervention Research, Fifth Affiliated Hospital of Wenzhou Medical University, Lishui 323000, China.
  • Chen M; Key Laboratory of Imaging Diagnosis and Minimally Invasive Intervention Research, Fifth Affiliated Hospital of Wenzhou Medical University, Lishui 323000, China.
  • Shu G; Key Laboratory of Imaging Diagnosis and Minimally Invasive Intervention Research, Fifth Affiliated Hospital of Wenzhou Medical University, Lishui 323000, China.
  • Zhang D; Key Laboratory of Imaging Diagnosis and Minimally Invasive Intervention Research, Fifth Affiliated Hospital of Wenzhou Medical University, Lishui 323000, China.
  • Kong C; Key Laboratory of Imaging Diagnosis and Minimally Invasive Intervention Research, Fifth Affiliated Hospital of Wenzhou Medical University, Lishui 323000, China.
  • Weng Q; Key Laboratory of Imaging Diagnosis and Minimally Invasive Intervention Research, Fifth Affiliated Hospital of Wenzhou Medical University, Lishui 323000, China.
  • Xu S; Clinical Laboratory, Fuyuan Hospital of Yiwu, Jinhua 321000, China. Electronic address: 475861146@qq.com.
  • Zhao Z; Key Laboratory of Imaging Diagnosis and Minimally Invasive Intervention Research, Fifth Affiliated Hospital of Wenzhou Medical University, Lishui 323000, China. Electronic address: zhaozw79@163.com.
  • Ji J; Key Laboratory of Imaging Diagnosis and Minimally Invasive Intervention Research, Fifth Affiliated Hospital of Wenzhou Medical University, Lishui 323000, China; Department of Radiology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China; Clinical College of the Affili
Pharmacol Res ; 177: 106140, 2022 03.
Article en En | MEDLINE | ID: mdl-35202819
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteínas Quinasas Activadas por AMP / Neoplasias Hepáticas Límite: Humans Idioma: En Revista: Pharmacol Res Asunto de la revista: FARMACOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Países Bajos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteínas Quinasas Activadas por AMP / Neoplasias Hepáticas Límite: Humans Idioma: En Revista: Pharmacol Res Asunto de la revista: FARMACOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Países Bajos